We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Gentex Q4 Earnings Miss Expectations, Sales Decline Y/Y
Read MoreHide Full Article
Gentex Corporation’s (GNTX - Free Report) fourth-quarter 2024 earnings per share (EPS) of 39 cents missed the Zacks Consensus Estimate of 49 cents and decreased 22% year over year.
This Zeeland-based automotive products supplier reported net sales of $542 million, which missed the Zacks Consensus Estimate of $602 million and fell 8% from the year-ago period. The company recorded a gross margin of 32.5%, reflecting a decline of 200 basis points from the fourth quarter of 2023 due to lower-than-expected sales, an unfavorable product mix and difficulty in spreading overhead costs efficiently.
The Automotive segment’s net sales — contributing the most to Gentex’s revenues — totaled $531.3 million in the fourth quarter, lower than the $578.7 million reported in the year-ago quarter and missed our estimate of $585.9 million. In the reported quarter, auto-dimming mirror shipments in the North American market decreased 10% to 3,438,000 units. Shipments fell 14% year over year in the international markets to 7,339,000 units. Total shipments declined 13% to 10,777,000 units.
Other net sales, which include dimmable aircraft windows, fire protection products and medical products decreased from the year-ago quarter’s $10.5 million to $10.3 million and lagged our estimate of $13.5 million. Fire protection sales increased 5% year over year, while dimmable aircraft window sales decreased 23% year over year. Medical product sales totaled $0.6 million in the fourth quarter of 2024.
Financial Tidbits
Total operating expenses rose 22% year over year to $86.5 million in fourth-quarter 2024. Engineering and R&D expenses increased to $47.06 million from $41.53 million. SG&A expenses rose to $30.53 million from $29.06 million recorded in the corresponding quarter of 2023.
GNTX paid a dividend of 12 cents per share in the quarter. It repurchased 603,396 shares of its common stock at an average price of $30.54 per share. As of Dec. 31, 2024, the company had nearly 9.4 million shares remaining for buyback, per its previously announced share repurchase plan. Gentex had cash and cash equivalents of about $233.3 million as of Dec. 31, 2024.
GNTX Provides 2025 Guidance
Gentex expects 2025 net sales in the range of $2.40-$2.45 billion compared with $2.31 billion recorded in 2024. The gross margin is projected in the band of 33.5-34.5% compared with the 33.3% reported in 2024. Capital expenditure is anticipated between $125 million and $150 million, while operating expenses are estimated in the band of $310-$320 million.
The Zacks Consensus Estimate for GELYY’s fiscal 2025 sales and earnings suggests year-over-year growth of 66.62% and 149.31%, respectively. EPS estimates for fiscal 2025 and 2026 have improved by 15 cents and 38 cents, respectively, in the past 30 days.
The Zacks Consensus Estimate for YMHAY’s 2025 sales and earnings suggests year-over-year growth of 8.69%and 19.07%, respectively. EPS estimates for 2025 have improved by a penny in the past 60 days.
The Zacks Consensus Estimate for ALSN’s 2025 sales and earnings suggests year-over-year growth of 6.67% and 11.40%, respectively. EPS estimates for 2025 have improved 3 cents in the past 30 days.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Gentex Q4 Earnings Miss Expectations, Sales Decline Y/Y
Gentex Corporation’s (GNTX - Free Report) fourth-quarter 2024 earnings per share (EPS) of 39 cents missed the Zacks Consensus Estimate of 49 cents and decreased 22% year over year.
This Zeeland-based automotive products supplier reported net sales of $542 million, which missed the Zacks Consensus Estimate of $602 million and fell 8% from the year-ago period. The company recorded a gross margin of 32.5%, reflecting a decline of 200 basis points from the fourth quarter of 2023 due to lower-than-expected sales, an unfavorable product mix and difficulty in spreading overhead costs efficiently.
See the Zacks Earnings Calendar to stay ahead of market-making news.
Gentex Corporation Price, Consensus and EPS Surprise
Gentex Corporation price-consensus-eps-surprise-chart | Gentex Corporation Quote
Segmental Performance
The Automotive segment’s net sales — contributing the most to Gentex’s revenues — totaled $531.3 million in the fourth quarter, lower than the $578.7 million reported in the year-ago quarter and missed our estimate of $585.9 million. In the reported quarter, auto-dimming mirror shipments in the North American market decreased 10% to 3,438,000 units. Shipments fell 14% year over year in the international markets to 7,339,000 units. Total shipments declined 13% to 10,777,000 units.
Other net sales, which include dimmable aircraft windows, fire protection products and medical products decreased from the year-ago quarter’s $10.5 million to $10.3 million and lagged our estimate of $13.5 million. Fire protection sales increased 5% year over year, while dimmable aircraft window sales decreased 23% year over year. Medical product sales totaled $0.6 million in the fourth quarter of 2024.
Financial Tidbits
Total operating expenses rose 22% year over year to $86.5 million in fourth-quarter 2024. Engineering and R&D expenses increased to $47.06 million from $41.53 million. SG&A expenses rose to $30.53 million from $29.06 million recorded in the corresponding quarter of 2023.
GNTX paid a dividend of 12 cents per share in the quarter. It repurchased 603,396 shares of its common stock at an average price of $30.54 per share. As of Dec. 31, 2024, the company had nearly 9.4 million shares remaining for buyback, per its previously announced share repurchase plan. Gentex had cash and cash equivalents of about $233.3 million as of Dec. 31, 2024.
GNTX Provides 2025 Guidance
Gentex expects 2025 net sales in the range of $2.40-$2.45 billion compared with $2.31 billion recorded in 2024. The gross margin is projected in the band of 33.5-34.5% compared with the 33.3% reported in 2024. Capital expenditure is anticipated between $125 million and $150 million, while operating expenses are estimated in the band of $310-$320 million.
Zacks Rank & Key Picks
GNTX carries a Zacks Rank #3 (Hold) at present.
Some better-ranked stocks in the auto space are Geely Automobile Holdings Limited (GELYY - Free Report) , Yamaha Motor Co., Ltd. (YMHAY - Free Report) and Allison Transmission Holdings, Inc. (ALSN - Free Report) . While GELYY sports a Zacks Rank #1 (Strong Buy), YMHAY and ALSN carry a Zacks Rank #2 (Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for GELYY’s fiscal 2025 sales and earnings suggests year-over-year growth of 66.62% and 149.31%, respectively. EPS estimates for fiscal 2025 and 2026 have improved by 15 cents and 38 cents, respectively, in the past 30 days.
The Zacks Consensus Estimate for YMHAY’s 2025 sales and earnings suggests year-over-year growth of 8.69%and 19.07%, respectively. EPS estimates for 2025 have improved by a penny in the past 60 days.
The Zacks Consensus Estimate for ALSN’s 2025 sales and earnings suggests year-over-year growth of 6.67% and 11.40%, respectively. EPS estimates for 2025 have improved 3 cents in the past 30 days.